Company page

Hvivo Plc

Hvivo Plc is a public company listed on the UK market under the ticker HVO, with a market capitalization of approximately £76.6 million. The company specializes in the development and commercialization of innovative solutions for infectious diseases. Hvivo focuses on advancing its capabilities in human challenge studies and related services to support vaccine and antiviral development.